Skip to main content
Erschienen in: Endocrine 2/2016

01.02.2016 | Original Article

Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?

verfasst von: Giovanna Muscogiuri, Vincenzo Nuzzo, Adriano Gatti, Alfonso Zuccoli, Silvia Savastano, Carolina Di Somma, Rosario Pivonello, Francesco Orio, Annamaria Colao

Erschienen in: Endocrine | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Vitamin D (25(OH)D) levels have been associated with cardiovascular disease. Thus, the aim of our study was to investigate the association of 25(OH)D levels with coronary heart disease (CHD) in 698 consecutive type 2 diabetic outpatients. 698 consecutive type 2 diabetic outpatients (25.2 % men, age 66 ± 9 years) and 100 (90 % men, age 65 ± 13 years) age-matched non-diabetic volunteers were enrolled. 25(OH)D assay and the main cardiovascular risk factors were explored. 25(OH)D concentration was 22 ± 10 ng/ml in control subjects and 18.23 ± 10 ng/ml in diabetic patients (p < 0.01). The prevalence of hypovitaminosis D was higher in diabetic patients than in control subjects (90 vs. 83 %, p < 0.01). Diabetic subjects with hypovitaminosis D had higher prevalence of high values of A1C (p < 0.01), BMI (p < 0.01), LDL cholesterol (p < 0.01), triglycerides (p < 0.01), and glycemia (p < 0.01) than their vitamin D-sufficient counterparts. 25(OH)D and HDL cholesterol were lower (p < 0.01), while BMI (p < 0.01), age (p < 0.01), systolic (p < 0.01) and diastolic blood pressure (p < 0.01), diabetes duration (p < 0.01), A1C (p < 0.01), glycemia (p < 0.01), fibrinogen (p < 0.01), triglycerides (p < 0.01), and total (p < 0.01) and LDL cholesterol (p < 0.01) were higher in diabetic subjects with CHD than diabetic subjects without CHD. At the logistic regression analysis, the association of vitamin D with CHD was lost, while sex (p = 0.026), diabetes duration (p = 0.023), and age (p = 0.024) were the most powerful predictors of CHD. The current study demonstrates that 25(OH)D does not have a direct effect on CHD but may have an indirect effect mediated by cardiovascular risk factors such as diabetes duration, age, and sex.
Literatur
2.
Zurück zum Zitat R. Scragg, M. Sowers, C. Bell, Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens. 20(7), 713–719 (2007)CrossRefPubMed R. Scragg, M. Sowers, C. Bell, Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens. 20(7), 713–719 (2007)CrossRefPubMed
3.
Zurück zum Zitat S. Pilz, H. Dobnig, J.E. Fischer, B. Wellnitz, U. Seelhorst, B.O. Boehm, W. März, Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 39(9), 2611–2613 (2008)CrossRefPubMed S. Pilz, H. Dobnig, J.E. Fischer, B. Wellnitz, U. Seelhorst, B.O. Boehm, W. März, Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 39(9), 2611–2613 (2008)CrossRefPubMed
4.
Zurück zum Zitat G. Muscogiuri, G.P. Sorice, R. Ajjan, T. Mezza, S. Pilz, A. Prioletta, R. Scragg, S.L. Volpe, M.D. Witham, A. Giaccari, Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr. Metab. Cardiovasc. Dis. 22(2), 81–87 (2012)CrossRefPubMed G. Muscogiuri, G.P. Sorice, R. Ajjan, T. Mezza, S. Pilz, A. Prioletta, R. Scragg, S.L. Volpe, M.D. Witham, A. Giaccari, Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr. Metab. Cardiovasc. Dis. 22(2), 81–87 (2012)CrossRefPubMed
5.
Zurück zum Zitat T. Mezza, G. Muscogiuri, G.P. Sorice, A. Prioletta, E. Salomone, A. Pontecorvi, A. Giaccari, Vitamin D deficiency: a new risk factor for type 2 diabetes? Ann. Nutr. Metab. 61(4), 337–348 (2012)CrossRefPubMed T. Mezza, G. Muscogiuri, G.P. Sorice, A. Prioletta, E. Salomone, A. Pontecorvi, A. Giaccari, Vitamin D deficiency: a new risk factor for type 2 diabetes? Ann. Nutr. Metab. 61(4), 337–348 (2012)CrossRefPubMed
6.
Zurück zum Zitat G. Muscogiuri, J. Mitri, C. Mathieu, K. Badenhoop, G. Tamer, F. Orio, T. Mezza, R. Vieth, A. Colao, A. Pittas, Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur. J. Endocrinol. 171(3), R101–R110 (2014)CrossRefPubMed G. Muscogiuri, J. Mitri, C. Mathieu, K. Badenhoop, G. Tamer, F. Orio, T. Mezza, R. Vieth, A. Colao, A. Pittas, Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur. J. Endocrinol. 171(3), R101–R110 (2014)CrossRefPubMed
7.
Zurück zum Zitat T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, K. Lanier, E.J. Benjamin, R.B. D’Agostino, M. Wolf, R.S. Vasan, Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4), 503–511 (2008)CrossRefPubMed T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, K. Lanier, E.J. Benjamin, R.B. D’Agostino, M. Wolf, R.S. Vasan, Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4), 503–511 (2008)CrossRefPubMed
8.
Zurück zum Zitat J. Kendrick, G. Targher, G. Smits, M. Chonchol, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 205(1), 255–260 (2009)CrossRefPubMed J. Kendrick, G. Targher, G. Smits, M. Chonchol, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 205(1), 255–260 (2009)CrossRefPubMed
9.
Zurück zum Zitat W. Messenger, C.M. Nielson, H. Li, T. Beer, E. Barrett-Connor, K. Stone, J. Shannon, Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr. Metab. Cardiovasc. Dis. 22(10), 856–863 (2012)CrossRefPubMedPubMedCentral W. Messenger, C.M. Nielson, H. Li, T. Beer, E. Barrett-Connor, K. Stone, J. Shannon, Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr. Metab. Cardiovasc. Dis. 22(10), 856–863 (2012)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat J.P. Forman, J.B. Scott, K. Ng, B.F. Drake, E.G. Suarez, D.L. Hayden, G.G. Bennett, P.D. Chandler, B.W. Hollis, K.M. Emmons, E.L. Giovannucci, C.S. Fuchs, A.T. Chan, Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61(4), 779–785 (2013)CrossRefPubMedPubMedCentral J.P. Forman, J.B. Scott, K. Ng, B.F. Drake, E.G. Suarez, D.L. Hayden, G.G. Bennett, P.D. Chandler, B.W. Hollis, K.M. Emmons, E.L. Giovannucci, C.S. Fuchs, A.T. Chan, Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61(4), 779–785 (2013)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat M.M. Donneyong, C.A. Hornung, K.C. Taylor, R.N. Baumgartner, J.A. Myers, C.B. Eaton, E.Z. Gorodeski, L. Klein, L.W. Martin, J.M. Shikany, Y. Song, W. Li, J.E. Manson, Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women’s health initiative. Circ. Heart Fail. (2014). doi:10.1161/CIRCHEARTFAILURE.114.001738 PubMedPubMedCentral M.M. Donneyong, C.A. Hornung, K.C. Taylor, R.N. Baumgartner, J.A. Myers, C.B. Eaton, E.Z. Gorodeski, L. Klein, L.W. Martin, J.M. Shikany, Y. Song, W. Li, J.E. Manson, Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women’s health initiative. Circ. Heart Fail. (2014). doi:10.​1161/​CIRCHEARTFAILURE​.​114.​001738 PubMedPubMedCentral
12.
Zurück zum Zitat L. Wang, J.E. Manson, Y. Song, H.D. Sesso, Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 152(5), 315–323 (2010)CrossRefPubMed L. Wang, J.E. Manson, Y. Song, H.D. Sesso, Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 152(5), 315–323 (2010)CrossRefPubMed
13.
Zurück zum Zitat M.B. Elamin, N.O. Abu Elnour, K.B. Elamin, M.M. Fatourechi, A.A. Alkatib, J.P. Almandoz, H. Liu, M.A. Lane, R.J. Mullan, A. Hazem, P.J. Erwin, D.D. Hensrud, M.H. Murad, V.M. Montori, Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96(7), 1931–1942 (2011)CrossRefPubMed M.B. Elamin, N.O. Abu Elnour, K.B. Elamin, M.M. Fatourechi, A.A. Alkatib, J.P. Almandoz, H. Liu, M.A. Lane, R.J. Mullan, A. Hazem, P.J. Erwin, D.D. Hensrud, M.H. Murad, V.M. Montori, Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96(7), 1931–1942 (2011)CrossRefPubMed
14.
Zurück zum Zitat L.G. Danescu, S. Levy, J. Levy, Vitamin D and diabetes mellitus. Endocrine 35(1), 11–17 (2009)CrossRefPubMed L.G. Danescu, S. Levy, J. Levy, Vitamin D and diabetes mellitus. Endocrine 35(1), 11–17 (2009)CrossRefPubMed
16.
Zurück zum Zitat Y. Song, L. Wang, A.G. Pittas, L.C. Del Gobbo, C. Zhang, J.E. Manson, F.B. Hu, Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36(5), 1422–1428 (2013)CrossRefPubMedPubMedCentral Y. Song, L. Wang, A.G. Pittas, L.C. Del Gobbo, C. Zhang, J.E. Manson, F.B. Hu, Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36(5), 1422–1428 (2013)CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat L. Wang, Y. Song, J.E. Manson, S. Pilz, W. März, K. Michaëlsson, A. Lundqvist, S.K. Jassal, E. Barrett-Connor, C. Zhang, C.B. Eaton, H.T. May, J.L. Anderson, H.D. Sesso, Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5(6), 819–829 (2012)CrossRefPubMedPubMedCentral L. Wang, Y. Song, J.E. Manson, S. Pilz, W. März, K. Michaëlsson, A. Lundqvist, S.K. Jassal, E. Barrett-Connor, C. Zhang, C.B. Eaton, H.T. May, J.L. Anderson, H.D. Sesso, Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5(6), 819–829 (2012)CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat J.L. Anderson, H.T. May, B.D. Horne, T.L. Bair, N.L. Hall, J.F. Carlquist, D.L. Lappé, J.B. Muhlestein, Intermountain Heart Collaborative (IHC) Study Group, Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106(7), 963–968 (2010)CrossRefPubMed J.L. Anderson, H.T. May, B.D. Horne, T.L. Bair, N.L. Hall, J.F. Carlquist, D.L. Lappé, J.B. Muhlestein, Intermountain Heart Collaborative (IHC) Study Group, Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106(7), 963–968 (2010)CrossRefPubMed
19.
Zurück zum Zitat M. Cigolini, M.P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, G. Targher, Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29(3), 722–724 (2006)CrossRefPubMed M. Cigolini, M.P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, G. Targher, Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29(3), 722–724 (2006)CrossRefPubMed
20.
Zurück zum Zitat G. Targher, L. Bertolini, R. Padovani, L. Zenari, L. Scala, M. Cigolini, G. Arcaro, Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. (Oxf.) 65(5), 593–597 (2006)CrossRef G. Targher, L. Bertolini, R. Padovani, L. Zenari, L. Scala, M. Cigolini, G. Arcaro, Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. (Oxf.) 65(5), 593–597 (2006)CrossRef
21.
Zurück zum Zitat J.I. Lee, S.J. Oh, W.C. Ha, H.S. Kwon, T.S. Sohn, H.S. Son, B.Y. Cha, Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diabetes Res. Clin. Pract. 95(1), 42–47 (2012)CrossRefPubMed J.I. Lee, S.J. Oh, W.C. Ha, H.S. Kwon, T.S. Sohn, H.S. Son, B.Y. Cha, Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diabetes Res. Clin. Pract. 95(1), 42–47 (2012)CrossRefPubMed
22.
Zurück zum Zitat C. Joergensen, H. Reinhard, A. Schmedes, P.R. Hansen, N. Wiinberg, C.L. Petersen, K. Winther, H.H. Parving, P.K. Jacobsen, P. Rossing, Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care 35(1), 168–172 (2012)CrossRefPubMedPubMedCentral C. Joergensen, H. Reinhard, A. Schmedes, P.R. Hansen, N. Wiinberg, C.L. Petersen, K. Winther, H.H. Parving, P.K. Jacobsen, P. Rossing, Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care 35(1), 168–172 (2012)CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat S. Bonakdaran, A.R. Varasteh, Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med. J. 30(4), 509–514 (2009)PubMed S. Bonakdaran, A.R. Varasteh, Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med. J. 30(4), 509–514 (2009)PubMed
24.
Zurück zum Zitat M. Chonchol, M. Cigolini, G. Targher, Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol. Dial. Transplant. 23(1), 269–274 (2008)CrossRefPubMed M. Chonchol, M. Cigolini, G. Targher, Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol. Dial. Transplant. 23(1), 269–274 (2008)CrossRefPubMed
25.
Zurück zum Zitat C. García-Cantón, E. Bosch, I. Auyanet, A. Ramírez, P. Rossique, C. Culebras, A. Sánchez, A. Toledo, M. Lago, N. Esparza, M.D. Checa, 25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with advanced chronic kidney disease. Nefrologia 30(4), 435–442 (2010)PubMed C. García-Cantón, E. Bosch, I. Auyanet, A. Ramírez, P. Rossique, C. Culebras, A. Sánchez, A. Toledo, M. Lago, N. Esparza, M.D. Checa, 25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with advanced chronic kidney disease. Nefrologia 30(4), 435–442 (2010)PubMed
26.
Zurück zum Zitat G. Targher, I. Pichiri, G. Lippi, Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin. Thromb. Hemost. 38(1), 114–124 (2012)CrossRefPubMed G. Targher, I. Pichiri, G. Lippi, Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin. Thromb. Hemost. 38(1), 114–124 (2012)CrossRefPubMed
27.
Zurück zum Zitat S.S. Sherman, B.W. Hollis, J.D. Tobin, Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J. Clin. Endocrinol. Metab. 71(2), 405–413 (1990)CrossRefPubMed S.S. Sherman, B.W. Hollis, J.D. Tobin, Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J. Clin. Endocrinol. Metab. 71(2), 405–413 (1990)CrossRefPubMed
28.
Zurück zum Zitat V. Carnevale, R. Minonne, A. De Matthaeis, M.A. Annese, P. Tabacco, P. D’Arcangelo, G. D’Amico, A. Scillitani, Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department. Endocrine (2014). doi:10.1007/s12020-014-0191-4 V. Carnevale, R. Minonne, A. De Matthaeis, M.A. Annese, P. Tabacco, P. D’Arcangelo, G. D’Amico, A. Scillitani, Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department. Endocrine (2014). doi:10.​1007/​s12020-014-0191-4
29.
Zurück zum Zitat G. Muscogiuri, G.P. Sorice, A. Prioletta, C. Policola, S. Della Casa, A. Pontecorvi, A. Giaccari, 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18(10), 1906–1910 (2010)CrossRef G. Muscogiuri, G.P. Sorice, A. Prioletta, C. Policola, S. Della Casa, A. Pontecorvi, A. Giaccari, 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18(10), 1906–1910 (2010)CrossRef
30.
Zurück zum Zitat G. Muscogiuri, C. Policola, A. Prioletta, G. Sorice, T. Mezza, A. Lassandro, S. Della Casa, A. Pontecorvi, A. Giaccari, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin. Nutr. 31(4), 476–480 (2012)CrossRefPubMed G. Muscogiuri, C. Policola, A. Prioletta, G. Sorice, T. Mezza, A. Lassandro, S. Della Casa, A. Pontecorvi, A. Giaccari, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin. Nutr. 31(4), 476–480 (2012)CrossRefPubMed
31.
Zurück zum Zitat L.J. Maple-Brown, J.T. Hughes, Z.X. Lu, K. Jeyaraman, P. Lawton, G.R. Jones, A. Ellis, A. Sinha, A. Cass, R.J. MacIsaac, G. Jerums, K. O’Dea, Serum vitamin D levels, diabetes and cardio-metabolic risk factors in Aboriginal and Torres Strait Islander Australians. Diabetol. Metab. Syndr. 6, 78 (2014)CrossRefPubMedPubMedCentral L.J. Maple-Brown, J.T. Hughes, Z.X. Lu, K. Jeyaraman, P. Lawton, G.R. Jones, A. Ellis, A. Sinha, A. Cass, R.J. MacIsaac, G. Jerums, K. O’Dea, Serum vitamin D levels, diabetes and cardio-metabolic risk factors in Aboriginal and Torres Strait Islander Australians. Diabetol. Metab. Syndr. 6, 78 (2014)CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat O.H. Ryu, W. Chung, S. Lee, K.S. Hong, M.G. Choi, H.J. Yoo, The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J. Intern. Med. 29(5), 620–629 (2014)CrossRefPubMedPubMedCentral O.H. Ryu, W. Chung, S. Lee, K.S. Hong, M.G. Choi, H.J. Yoo, The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J. Intern. Med. 29(5), 620–629 (2014)CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat F.L. Vélayoudom-Céphise, L. Larifla, J.P. Donnet, S. Maimaitiming, J. Deloumeaux, A. Blanchet, C. Massart, N. Munoz-Bellili, S. Merle, R. Chout, F. Bonnet, L. Foucan, Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab. 37(6), 540–545 (2011)CrossRefPubMed F.L. Vélayoudom-Céphise, L. Larifla, J.P. Donnet, S. Maimaitiming, J. Deloumeaux, A. Blanchet, C. Massart, N. Munoz-Bellili, S. Merle, R. Chout, F. Bonnet, L. Foucan, Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab. 37(6), 540–545 (2011)CrossRefPubMed
Metadaten
Titel
Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?
verfasst von
Giovanna Muscogiuri
Vincenzo Nuzzo
Adriano Gatti
Alfonso Zuccoli
Silvia Savastano
Carolina Di Somma
Rosario Pivonello
Francesco Orio
Annamaria Colao
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0609-7

Weitere Artikel der Ausgabe 2/2016

Endocrine 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.